{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:00:52Z","timestamp":1794607252094,"version":"4.9.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jem-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Emergency Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jemermed.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T02:01:09Z","timestamp":1710208869000},"page":"e31-e41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["A Clinical Review of Vasopressors in Emergency Medicine"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1516-3510","authenticated-orcid":false,"given":"Matthew","family":"Stampfl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"DeBlieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jemermed.2024.03.004_bib0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/978-1-4615-9014-9_3","article-title":"Proposed reclassification of shock states with special reference to distributive defects","volume":"23","author":"Weil","year":"1971","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0002","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/SHK.0000000000000816","article-title":"Etiology of shock in the emergency department: a 12-year population-based cohort study","volume":"51","author":"Gitz Holler","year":"2019","journal-title":"Shock."},{"key":"10.1016\/j.jemermed.2024.03.004_bib0003","first-page":"115","article-title":"Shock in the emergency department: incidence, etiology, and mortality","volume":"103","author":"Phungoen","year":"2020","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0004","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","article-title":"Outcome of patients with septic shock and high-dose vasopressor therapy","volume":"7","author":"Auchet","year":"2017","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1177\/0310057X0903700212","article-title":"Outcome of patients receiving high dose vasopressor therapy: a retrospective cohort study","volume":"37","author":"Jenkins","year":"2009","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0006","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/SHK.0000000000001609","article-title":"Abrupt discontinuation versus down-titration of vasopressin in patients recovering from septic shock","volume":"55","author":"Lam","year":"2021","journal-title":"Shock"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0007","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1592\/phco.24.11.1002.36139","article-title":"Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock","volume":"24","author":"Hall","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0008","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0009","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0010","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/1742-6723.13469","article-title":"The Australasian resuscitation in sepsis evaluation: fluids or vasopressors in emergency department sepsis (ARISE FLUIDS), a multi-centre observational study describing current practice in Australia and New Zealand","volume":"32","author":"Keijzers","year":"2020","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0011","doi-asserted-by":"crossref","first-page":"794","DOI":"10.21037\/atm.2020.04.24","article-title":"Vasopressors in septic shock: which, when, and how much?","volume":"8","author":"Shi","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0012","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s13054-014-0532-y","article-title":"Early versus delayed administration of norepinephrine in patients with septic shock","volume":"18","author":"Bai","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0013","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","article-title":"Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial","volume":"199","author":"Permpikul","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0014","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12879-022-07337-y","article-title":"Prehospital norepinephrine administration reduces 30-day mortality among septic shock patients","volume":"22","author":"Jouffroy","year":"2022","journal-title":"BMC Infect. Dis"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/1742-6723.13394","article-title":"Initiation of vasopressor infusions via peripheral versus central access in patients with early septic shock: a retrospective cohort study","volume":"32","author":"Delaney","year":"2020","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0017","doi-asserted-by":"crossref","first-page":"E127","DOI":"10.9778\/cmajo.20130006","article-title":"Prescribed targets for titration of vasopressors in septic shock: a retrospective cohort study","volume":"1","author":"St-Arnaud","year":"2013","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0018","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"47","author":"Evans","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0019","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s12630-017-0877-1","article-title":"A systematic review of vasopressor blood pressure targets in critically ill adults with hypotension","volume":"64","author":"Hylands","year":"2017","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0020","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0021","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s00134-016-4237-3","article-title":"Higher versus lower blood pressure targets for vasopressor therapy in shock: a multicentre pilot randomized controlled trial","volume":"42","author":"Lamontagne","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0022","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically Ill patients with vasodilatory hypotension: a randomized clinical trial","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0023","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJMoa2208687","article-title":"Blood-pressure targets in comatose survivors of cardiac arrest","volume":"387","author":"Kjaergaard","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0024","first-page":"437","article-title":"Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness","volume":"88","author":"Weil","year":"1958","journal-title":"Calif Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1378\/chest.33.1.18","article-title":"Depressed response to intravenous sympathicomimetic agents in humans during acidosis","volume":"33","author":"Campbell","year":"1958","journal-title":"Dis Chest"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0026","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2165\/00003495-200363030-00001","article-title":"Management of vasodilatory shock: defining the role of arginine vasopressin","volume":"63","author":"Dunser","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0027","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00134-004-2283-8","article-title":"Role of vasopressin in the management of septic shock","volume":"30","author":"Mutlu","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0028","doi-asserted-by":"crossref","first-page":"e0634","DOI":"10.1097\/CCE.0000000000000634","article-title":"Association of arterial pH with hemodynamic response to vasopressin in patients with septic shock: an observational cohort study","volume":"4","author":"Bauer","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13054-020-03431-2","article-title":"Incidence and management of metabolic acidosis with sodium bicarbonate in the ICU: an international observational study","volume":"25","author":"Fujii","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)31080-8","article-title":"Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial","volume":"392","author":"Jaber","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0031","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.jemermed.2023.04.012","article-title":"A review of bicarbonate use in common clinical scenarios","volume":"65","author":"Wardi","year":"2023","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0032","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.chest.2017.12.021","article-title":"Management of refractory vasodilatory shock","volume":"154","author":"Jentzer","year":"2018","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.jemermed.2024.03.004_bib0033","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jemermed.2020.09.022","article-title":"Hemodynamic Instability and Abnormal Vasopressor Responsiveness in the Setting of Severe Metabolic Acidosis Treated With Adapted Alkalinization and Continuous Renal Replacement Therapy in the Emergency Department","volume":"60","author":"Drumheller","year":"2021","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0034","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0272-6386(12)81007-9","article-title":"Refractory hypotension associated with hypocalcemia and renal disease","volume":"23","author":"Ghent","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0035","series-title":"C44. Critical Care Case Reports: Metabolic, Renal, And Endocrine. American Thoracic Society International Conference Abstracts","first-page":"A5160","article-title":"Hypocalcemia: a rare cause of hypotension","author":"Park","year":"2020"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0036","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/00003246-198806000-00002","article-title":"A direct relationship between ionized calcium and arterial pressure among patients in an intensive care unit","volume":"16","author":"Desai","year":"1988","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0037","first-page":"529","article-title":"Short-term hemodynamic response to calcium supplementation in patients with refractory septic shock: a retrospective observational study","volume":"30","author":"Chang","year":"2019","journal-title":"J Korean Soc Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0038","first-page":"197","article-title":"Hemodynamic effects of intravenous calcium administration on septic shock patients: a retrospective study","volume":"69","author":"Ishibashi","year":"2015","journal-title":"Acta Med Okayama"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0039","doi-asserted-by":"crossref","first-page":"339.e1","DOI":"10.1016\/j.amjmed.2015.08.021","article-title":"Adrenal crisis: still a deadly event in the 21st century","volume":"129","author":"Puar","year":"2016","journal-title":"Am. J. Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0040","doi-asserted-by":"crossref","first-page":"bvad017","DOI":"10.1210\/jendso\/bvad017","article-title":"The changing epidemiology of adrenal insufficiency: iatrogenic factors predominate","volume":"7","author":"Rushworth","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0041","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0042","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ajem.2020.09.062","article-title":"Decompensated hypothyroidism: a review for the emergency clinician","volume":"39","author":"Bridwell","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0043","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.emc.2016.09.005","article-title":"Vasopressors and inotropes in sepsis","volume":"35","author":"Stratton","year":"2017","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0044","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/1742-6723.13406","article-title":"Safety of peripheral administration of vasopressor medications: a systematic review","volume":"32","author":"Tian","year":"2020","journal-title":"Emerg Med Australas"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13054-021-03553-1","article-title":"Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis","volume":"25","author":"Owen","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0046","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1177\/0885066618795126","article-title":"Anatomic site-specific complication rates for central venous catheter insertions","volume":"35","author":"Bell","year":"2020","journal-title":"J Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0047","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bja.2022.08.036","article-title":"Mechanical complications after central venous catheterisation in the ultrasound-guided era: a prospective multicentre cohort study","volume":"129","author":"Adrian","year":"2022","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0048","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/phar.1396","article-title":"Management of extravasation injuries: a focused evaluation of noncytotoxic medications","volume":"34","author":"Reynolds","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0049","first-page":"581","article-title":"Alternative pharmacological management of vasopressor extravasation in the absence of phentolamine","volume":"42","author":"Plum","year":"2017","journal-title":"P T"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0050","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/jhm.2394","article-title":"Safety of peripheral intravenous administration of vasoactive medication","volume":"10","author":"Cardenas-Garcia","year":"2015","journal-title":"J Hosp Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0051","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5430\/ijh.v4n1p36","article-title":"The development of a nurse-driven protocol for the safe administration of vasopressors through peripheral intravenous catheters","volume":"4","author":"Padrone","year":"2018","journal-title":"Int J Healthc"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0052","series-title":"D44. Critical Care: The Room Where It Happens\u2014How We Manage Critical Care in And Out of the Icu. American Thoracic Society International Conference Abstracts","first-page":"A6854","article-title":"Implementation of an ICU protocol for peripheral administration of vasopressors","author":"Patel","year":"2018"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0053","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.ccm.0000909652.27778.b0","article-title":"981: change in attitude from central to peripheral vasopressor administration","volume":"51","author":"Kumar","year":"2023","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0054","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1177\/08971900221096967","article-title":"A Review of Push-Dose Vasopressors in the Peri-operative and Critical Care Setting","volume":"36","author":"McPherson","year":"2023","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ajem.2021.07.006","article-title":"Efficacy of bolus-dose epinephrine to manage hypotension in the prehospital setting","volume":"50","author":"Weant","year":"2021","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0056","doi-asserted-by":"crossref","first-page":"131","DOI":"10.15441\/ceem.15.010","article-title":"Push-dose pressors for immediate blood pressure control","volume":"2","author":"Weingart","year":"2015","journal-title":"Clin Exp Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0057","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajem.2021.11.033","article-title":"Comparison of push-dose phenylephrine and epinephrine in the emergency department","volume":"52","author":"Nam","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0058","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jemermed.2019.12.026","article-title":"Push-dose vasopressin for hypotension in septic shock","volume":"58","author":"Nowadly","year":"2020","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0059","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ajem.2022.08.055","article-title":"The safety and efficacy of push dose vasopressors in critically ill adults","volume":"61","author":"Singer","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/jeccm-21-98","article-title":"Push-dose vasopressors in the emergency department: a narrative review","volume":"6","author":"Kubena","year":"2022","journal-title":"J Emerg Crit Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0061","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s13181-019-00716-z","article-title":"Human errors and adverse hemodynamic events related to \u201cpush dose pressors\u201d in the emergency department","volume":"15","author":"Cole","year":"2019","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0062","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.annemergmed.2017.04.021","article-title":"Safety considerations and guideline-based safe use recommendations for \u201cbolus-dose\u201d vasopressors in the emergency department","volume":"71","author":"Holden","year":"2018","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0063","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0064","first-page":"185","article-title":"Vasopressin versus norepinephrine as the first-line vasopressor in septic shock: a systematic review and meta-analysis","volume":"8","author":"Sedhai","year":"2022","journal-title":"J Clin Transl Res"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0065","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.4528","article-title":"Association of vasopressin plus catecholamine vasopressors vs catecholamines alone with atrial fibrillation in patients with distributive shock: a systematic review and meta-analysis","volume":"319","author":"McIntyre","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0066","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","article-title":"A comparison of epinephrine and norepinephrine in critically ill patients","volume":"34","author":"Myburgh","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0067","doi-asserted-by":"crossref","first-page":"A407","DOI":"10.1016\/j.chest.2017.08.433","article-title":"Comparison of vasopressin and epinephrine as the second vasopressor in the treatment of septic shock","volume":"152","author":"Kim","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0068","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00134-020-06012-7","article-title":"Vasopressin versus epinephrine as adjunct vasopressors for septic shock","volume":"46","author":"Aso","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0069","first-page":"S18","article-title":"Epinephrine: the drug of choice for anaphylaxis\u2013a statement of the World Allergy Organization","volume":"1","author":"Kemp","year":"2008","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0070","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1213\/ane.0b013e3181770b42","article-title":"The pivotal role of vasopressin in refractory anaphylactic shock","volume":"107","author":"Schummer","year":"2008","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0071","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12028-017-0462-z","article-title":"Emergency neurological life support: traumatic spine injury","volume":"27","author":"Stein","year":"2017","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0072","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.3171\/2017.8.FOCUS17428","article-title":"The impact of blood pressure management after spinal cord injury: a systematic review of the literature","volume":"43","author":"Saadeh","year":"2017","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0073","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1227\/01.neu.0000430319.32247.7f","article-title":"Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update","volume":"60","author":"Walters","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0074","unstructured":"Trauma C ATLS Advanced Trauma Life Support 10th edn Student Course Manual. American College of Surgeons; 2018."},{"key":"10.1016\/j.jemermed.2024.03.004_bib0075","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00068-017-0862-y","article-title":"Permissive hypotensive resuscitation in adult patients with traumatic haemorrhagic shock: a systematic review","volume":"44","author":"Albreiki","year":"2018","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0076","article-title":"Early vasopressor use following traumatic injury: a systematic review","volume":"7","author":"Hylands","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0077","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.34258","article-title":"Association of early norepinephrine administration with 24-hour mortality among patients with blunt trauma and hemorrhagic shock","volume":"5","author":"Gauss","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0078","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/jamasurg.2019.2884","article-title":"Effect of low-dose supplementation of arginine vasopressin on need for blood product transfusions in patients with trauma and hemorrhagic shock: a randomized clinical trial","volume":"154","author":"Sims","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/cem.2014.77","article-title":"Vasopressor and inotrope use in Canadian emergency departments: evidence based consensus guidelines","author":"Djogovic","year":"2015","journal-title":"CJEM"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0080","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/aas.12780","article-title":"Scandinavian SSAI clinical practice guideline on choice of first-line vasopressor for patients with acute circulatory failure","volume":"60","author":"M\u00f8ller","year":"2016","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0081","doi-asserted-by":"crossref","first-page":"546","DOI":"10.2215\/CJN.01820407","article-title":"Approach to hemodynamic shock and vasopressors","volume":"3","author":"Herget-Rosenthal","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0082","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0083","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.ajem.2020.09.045","article-title":"Identifying cardiogenic shock in the emergency department","volume":"38","author":"Daly","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0084","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3390\/jcm9072051","article-title":"Vasopressors and inotropes in acute myocardial infarction related cardiogenic shock: a systematic review and meta-analysis","volume":"9","author":"Karami","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0085","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0086","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/SHK.0000000000001830","article-title":"Comparison of clinical outcomes with initial norepinephrine or epinephrine for hemodynamic support after return of spontaneous circulation","volume":"56","author":"Weiss","year":"2021","journal-title":"Shock"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0087","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00134-021-06608-7","article-title":"Epinephrine versus norepinephrine in cardiac arrest patients with post-resuscitation shock","volume":"48","author":"Bougouin","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0088","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/15563650.2017.1284329","article-title":"Are vasopressors useful in toxin-induced cardiogenic shock?","volume":"55","author":"Skoog","year":"2017","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0089","doi-asserted-by":"crossref","first-page":"228.e5","DOI":"10.1016\/j.ajem.2022.01.014","article-title":"An unusual etiology of obstructive shock in the emergency department","volume":"55","author":"Murphy","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.5114\/aoms.2012.32402","article-title":"Management of massive and nonmassive pulmonary embolism","volume":"8","author":"Sekhri","year":"2012","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0091","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0092","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/bjaed\/mkw074","article-title":"Critical care management of pulmonary hypertension","volume":"17","author":"Condliffe","year":"2017","journal-title":"BJA Educ"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0093","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1510\/icvts.2007.159624","article-title":"Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension","volume":"6","author":"Tayama","year":"2007","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jemermed.2024.03.004_bib0094","first-page":"240","article-title":"Choosing a vasopressor for a prehospital emergency medical system: consideration for agent selection and review of pharmacologic profiles, efficacy, and safety in treatment of shock","volume":"119","author":"Feldman","year":"2020","journal-title":"WMJ"}],"container-title":["The Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467924000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0736467924000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T05:36:04Z","timestamp":1718429764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0736467924000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0736467924000726"],"URL":"https:\/\/doi.org\/10.1016\/j.jemermed.2024.03.004","relation":{},"ISSN":["0736-4679"],"issn-type":[{"value":"0736-4679","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Clinical Review of Vasopressors in Emergency Medicine","name":"articletitle","label":"Article Title"},{"value":"The Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jemermed.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}